Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | TTR | P02766 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.69 |
| ▸ | APP | P05067 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 2/20 | 0.69 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.69 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.69 |
| ▸ | DPP4 | P27487 | 2/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.69 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.69 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8916399 | 1.00 | KDM4E (0.69) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL29773361 | 1.00 | KDM4E (0.69) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| Phenol SCHEMBL28949254 | 0.90 | MMP1 (0.62) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL2221673 | 0.83 | KDM4E (0.74) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL5598948 | 0.83 | KDM4E (0.74) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30740005 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30739974 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL21986709 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL30740008 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 | |
| SCHEMBL21986714 | 0.83 | PELI1 (0.53) | KDM4EMAPTTTRKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118919149-A | Corrosion-resistant low-voltage cable and preparation method thereof | 启源电气股份有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118146694-A | Epoxy pipeline paint for cast iron pipe and cast iron fitting for building drainage and preparation method thereof | 江苏进华重防腐涂料有限公司 | 2024-06-07 | — | — | CN | claimed |
| EP-4228667-A1 | METHODS FOR REVERSING HEPATIC STEATOSIS | Brightseed, Inc. (US) | 2023-08-23 | — | — | EP | claimed |
| CN-115536604-A | Caffeic acid amide compound and application thereof | 广西大学 | 2022-12-30 | — | — | CN | claimed |
| EP-4003060-A1 | METHOD FOR IMPROVING DIGESTIVE HEALTH | Brightseed, Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| WO-2022081567-A1 | METHODS FOR REVERSING HEPATIC STEATOSIS | BRIGHTSEED, INC. (US) | 2022-04-21 | — | — | WO | claimed |
| CN-110643061-B | Preparation method of formamide-free environment-friendly rubber and plastic foamed product | 神州节能科技集团有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-112194691-A | Method for preparing catalpol and catalpol derivative based on radix rehmanniae preparata and application of catalpol derivative | 河北仁心药业有限公司 | 2021-01-08 | — | — | CN | claimed |
| CN-110643061-A | Preparation method of formamide-free environment-friendly rubber and plastic foamed product | 神州节能科技集团有限公司 | 2020-01-03 | — | — | CN | claimed |
| CN-104274433-B | application of caffeic acid amide derivative | 中国医药大学 | 2017-01-04 | — | — | CN | claimed |
| CN-104274433-A | application of caffeic acid amide derivative | UNIV CHINA MEDICAL | 2015-01-14 | — | — | CN | claimed |
| US-8450337-B2 | Methods of treating skin disorders with caffeic acid analogs | MOLECULIN, LLC (US) | 2013-05-28 | — | — | US | claimed |
| US-20100152143-A1 | Methods of Treating Skin Disorders with Caffeic Acid Analogs | MOLECULIN, LLC (US) | 2010-06-17 | — | — | US | claimed |
| EP-0971743-B1 | STABILIZED MEDICAMENTS CONTAINING CYSTEINYL DERIVATIVES | STANISLAUS FRITZ (DE) | 2006-07-12 | — | — | EP | claimed |
| US-20030119909-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS, FRITZ (DE) | 2003-06-26 | — | — | US | claimed |
| US-20020037855-A1 | Stabilized medicament containing cysteinyl derivatives | STANISLAUS FRITZ (DE) | 2002-03-28 | — | — | US | claimed |
| US-5686082-A | AN ANTIOXIDIZING SYSTEM | L'OREAL (FR) | 1997-11-11 | — | — | US | claimed |
| JP-5058978-A | — | — | None | — | — | JP | disclosed |
| JP-H02104568-A | ACTING AGENT OF PRODUCTION PROMOTION OF NERVE GROWTH FACTOR | YOSHITOMI PHARMACEUT IND LTD | 1990-04-17 | — | — | JP | disclosed |
| JP-H00710739-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152143-A1 | Methods of Treating Skin Disorders with Caffeic Acid Analogs | CUTA, TYR, PPARA | KDM4E 662/4885MAPT 784/4885TTR 2325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.